Pharmaceutical

City of Hope develops cell therapy for ovarian cancer

City of Hope researchers are developing a chimeric antigen receptor (CAR) T cell therapy for the treatment of recurrent ovarian cancer.

Aug 12, 2023 - 20:00
City of Hope develops cell therapy for ovarian cancer
City of Hope researchers are developing a chimeric antigen receptor (CAR) T cell therapy for the treatment of recurrent ovarian cancer.
Read the original article

Tags:

Previous Article

FDA accepts Astellas’ sNDA for CRESEMBA to treat fungal infections

Next Article

Battery and Shutdown Issues Lead to Another Class 1 Warning for Getinge’s Heart ...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Bristol Myers will pay $4.1 billion for cancer startup RayzeBio

STAT+: Bristol Myers will pay $4.1 billion for cancer s...

Dec 27, 2023

STAT+: Pharmalittle: Pharma hopes reformulated drugs will skirt Medicare negotiations; Biogen to acquire Reata for $7.3 billion

STAT+: Pharmalittle: Pharma hopes reformulated drugs wi...

Jul 28, 2023

ATX-304 by Amplifier TX for Cardiometabolic Disease: Li...

Nov 16, 2023